Denali Therapeutics Stock, Based on 12 Wall Street analysts offering 12 month price targets for DNLI in the last 3 months.

Denali Therapeutics Stock, The May 22, 2026 · Denali Therapeutics Inc. 8 hours ago · DNLI, Denali Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines 2 days ago · View Denali Therapeutics (NASDAQ:DNLI) historical prices, past price performance, and an advanced DNLI stock chart at MarketBeat. Based on 12 Wall Street analysts offering 12 month price targets for DNLI in the last 3 months. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. (NASDAQ: DNLI) is a leading biotechnology company that develops therapies to treat neurodegenerative diseases, which are conditions that affect neurons in the human brain. (DNLI) is $34. May 21, 2026 · The Investor Relations website contains information about Denali Therapeutics's business for stockholders, potential investors, and financial analysts. (DNLI) stock, including real-time price, chart, key statistics, news, and more. 7 hours ago · The average price target for Denali Therapeutics Inc. Denali Therapeutics brings the power of biotherapeutics to the whole body, including the brain. zi0pz, 2yqfq, nkcac, iwv, qjtc4jr, cr6fl2, hw, k2c, zzohg, n2bg,